‘All parameters met’: Patanjali claims Coronil clinical trial details furnished to Centre

Centre had asked Patanjali Ayurveda Limited to suspend advertisements and provide details of clinical trials and of meeting necessary regulations and licence conditions before projecting Coronil as a medicine to treat coronavirus.

Yoga guru Ramdev addresses the media during the launch of ‘Coronil’ and ‘Swasari’, ayurvedic medicines claimed by Patanjali to cure coronavirus disease, in Haridwar on Tuesday

A senior functionary associated with yoga guru Ramdev has claimed that the Central government has been provided with all the necessary details of clinical trials of Coronil- the product launched on Tuesday by Patanjali Ayurved ltd, founded by the yoga guru, as alleged treatment for coronavirus patients.

Ramdev’s associate Acharya Balakrishna tweeted a clarification to claim that 100% parameters laid down for controlled trial of this Ayurvedic product have been followed by the company after Patanjali Ayurved Ltd was asked by the AYUSH ministry of government of India to suspend advertisements promoting use of Coronil, launched on Tuesday, as an effective treatment for the deadly Covid-19 infection.

“This government encourages Ayurveda and works for its glory, the communication gap has been filled and the Ayush ministry has been given all the information regarding the 100% fulfillment of all the standard parameters of Randomized Placebo Controlled Clinical Trials (of Coronil),” Balakrishna tweeted.

His tweet followed AYUSH ministry asking Patanjali Ayurveda Limited to provide the composition and other details of the alleged Ayurvedic medicine to treat Coved-19 and putting on hold the product’s advertisements until an examination of its claim.

Patanjali Ayurveda has launched the ‘Coronil and Swasari’ products with the claim that it has successfully cured scores of under-trial Covid-19 patients with 100% results except for those on life support systems.

Yoga guru Ramdev addresses the media during the launch of ‘Coronil’ and ‘Swasari’, ayurvedic medicines claimed by Patanjali to cure coronavirus disease, in Haridwar on Tuesday.(PTI Photo)Updated: Jun 24, 2020 06:49 ISTBy hindustantimes.com | Edited by Abhinav Sahay , Hindustan Times, New Delhi

A senior functionary associated the yoga guru, as alleged treatment for coronavirus patients.null

Ramdev’s associate Acharya Balakrishna tweeted a clarification to claim that 100% parameters laid down for controlled trial of this Ayurvedic product have been followed by the company after Patanjali Ayurved Ltd was asked by the AYUSH ministry of government of India to suspend advertisements promoting use of Coronil, launched on Tuesday, as an effective treatment for the deadly Covid-19 infection.

“This government encourages Ayurveda and works for its glory, the communication gap has been filled and the Ayush ministry has been given all the information regarding the 100% fulfillment of all the standard parameters of Randomized Placebo Controlled Clinical Trials (of Coronil),” Balakrishna tweeted.

His tweet followed AYUSH ministry asking Patanjali Ayurveda Limited to provide the composition and other details of the alleged Ayurvedic medicine to treat Coved-19 and putting on hold the product’s advertisements until an examination of its claim.

Patanjali Ayurveda has launched the ‘Coronil and Swasari’ products with the claim that it has successfully cured scores of under-trial Covid-19 patients with 100% results except for those on life support systems.

The ministry asked Patanjali to submit details of the sample size, sites and hospitals where the research study was conducted and also for the Institutional Ethics Committee clearance

Patanjali launched two medicines named Coronil and Swasari on Tuesday and claimed the clinical trials on affected patients have shown 100 per cent favourable results.

“The whole country and the world was waiting for medicine or vaccine for coronavirus. We are proud to announce that the first Ayurvedic, clinically controlled trial based evidence and research-based medicine has been prepared by the combined efforts of Patanjali Research Centre and NIMS,” Ramdev announced at a press conference in Hairdwar.

He claimed the first clinical controlled study on 280 patients took place in Delhi and Ahmedabad among many other cities. Ramdev said the recovery rate of patients was 100 per cent.

More than 4.4 lakh people have been affected by Covid-19 in India so far. The pandemic has claimed more than 14,000 lives till now.

Published by navjot singh

The past is no more and the future is not yet: both are unnecessarily moving in directions which don't exist. ...

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: